Your Flagship Event Driving ADC Innovation, Insights & Connections

Pfizer pens $10B, 12-drug deal with Innovent in broad bet on Chinese cancer med innovation
Iza-Bren Is Approved in China for Recurrent/Metastatic Nasopharyngeal Carcinoma
Novartis to acquire Myricx Bio for up to $1.5B, adding cancer-fighting ADC payload platform
Daiichi, AstraZeneca’s Enhertu breaks into early breast cancer with dual FDA approvals
Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC, fueling TROP2 ADC market war
J&J makes $1B upfront bet on emerging DAC space by netting Firefly Bio

Characterizing Containment Bags as a Development Tool in ADC Lyophilization

Characterizing Containment Bags as a Development Tool in ADC Lyophilization

2:00 pm - Wednesday 14th October 2026

Evaluating effectiveness of containment bags in a development setting to enable ADC lyophilization for characterization and stability
Demonstrating ice slab sublimation testing as a tool to characterize heat and mass transfer effects of containment bags
Characterizing heat and mass transfer and load effects to improve the relevance of containment bags to process development

Speakers:

Aaron Pruett

Aaron Pruett

Principal Scientist, Drug Product Sciences

MacroGenics